NIH researchers will highlight a novel Covid-19 diagnostic technology from the National Eye Institute (NEI). NEI is seeking partners for collaboration and licensing to accelerate technology development and clinical benefit. [….]
NCI Tech Opportunity Webinar: Use of Tempol as an Antiviral Therapeutic Against COVID-19
Published on :Attendees will hear from NICHD’s Dr. Tracey Rouault about the potential to formulate the compound, Tempol, into a preventative and oral treatment for COVID-19. The replication of the SARS-CoV-2’s genome [….]
Rockville’s MacroGenics Enters Research Collaboration with Sweden’s Alligator Bioscience to Develop a Novel Immunotherapy
Under the joint research collaboration agreement, which covers activities from candidate drug generation up until IND-enabling studies, each company will be responsible for its own costs. The parties may continue further development of the resulting bispecific molecule under a separate co-development collaboration and licensing agreement.